Literature DB >> 825014

Vaccination against bovine brucellosis with a low dose of strain 19 administered by the conjunctival route.

M Plommet, A M Plommet.   

Abstract

Eighteen 25 month old cows were vaccinated once either with 10(6) to 10(10) living bacteria of Brucella abortus B 19 by the conjunctival route, or with 2.5 to 5 X 10(10) formalin-killed bacteria of the same strain by subcutaneous injection. Fifteen days post-vaccination, low but definite agglutination titers were present in sera of cattle receiving 10(10) living bacteria by the conjunctival route, whereas high titers were observed in the control group given subcutaneous injection of killed bacteria (table I). Agglutination reactions were negative in sera from all cattle receiving less than 10(10) bacteria, and complement fixation tests were negative with all sera. Seventy-one 4 month old claves were vaccinated by the conjunctival route with different doses (10(6) to 10(10)) of living bacteria, either freshly prepared or lyophilized. At autopsy about 15 or about 30 days later, the parotid, submaxillary and retropharyngeal lymph nodes were removed and cultured on Brucella selective medium. Blood samples were taken at autopsy for testing by agglutination, complement fixation, Coombs test and (for some samples) by the Rose Bengal plate test. Colonization of at least one lymph node was observed in 26 of 34 calves given 10(9) bacteria, in all 9 calves given 5 X 10(9) bacteria and in all 12 calves given 10(10) bacteria. Serological responses were demonstrated rarely, and then only in agglutination and Coombs tests. The 5 X 10(9) dose, wich following conjunctival inoculation consistently colonized the regional lymph nodes without inducing significant serological response, would be the most suitable dose for the vaccination of calves and cows.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825014

Source DB:  PubMed          Journal:  Ann Rech Vet        ISSN: 0003-4193


  6 in total

1.  Vaccination of adult animals with a reduced dose of Brucella abortus S19 vaccine to control brucellosis on dairy farms in endemic areas of India.

Authors:  Puran Chand; Rajesh Chhabra; Juhi Nagra
Journal:  Trop Anim Health Prod       Date:  2014-10-02       Impact factor: 1.559

2.  Facing the Human and Animal Brucellosis Conundrums: The Forgotten Lessons.

Authors:  Edgardo Moreno; José-María Blasco; Ignacio Moriyón
Journal:  Microorganisms       Date:  2022-04-30

3.  Quantification of Brucella abortus population structure in a natural host.

Authors:  Aretha Fiebig; Catherine E Vrentas; Thien Le; Marianne Huebner; Paola M Boggiatto; Steven C Olsen; Sean Crosson
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 12.779

4.  Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle.

Authors:  Carlos Chacón-Díaz; Ana Zabalza-Baranguá; Beatriz San Román; José-María Blasco; Maite Iriarte; Dariana Salas-Alfaro; Gabriela Hernández-Mora; Elías Barquero-Calvo; Caterina Guzmán-Verri; Esteban Chaves-Olarte; María-Jesús Grilló; Edgardo Moreno
Journal:  PLoS One       Date:  2021-11-22       Impact factor: 3.240

5.  Cervical Lymph Nodes as a Selective Niche for Brucella during Oral Infections.

Authors:  Kristine von Bargen; Aurélie Gagnaire; Vilma Arce-Gorvel; Béatrice de Bovis; Fannie Baudimont; Lionel Chasson; Mile Bosilkovski; Alexia Papadopoulos; Anna Martirosyan; Sandrine Henri; Jean-Louis Mège; Bernard Malissen; Jean-Pierre Gorvel
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

6.  Humoral immune response to Salmonella abortusovis in sheep: in vitro induction of an antibody synthesis from either sensitized or unprimed lymph node cells.

Authors:  P Berthon; I Gohin; I Lantier; M Olivier
Journal:  Vet Immunol Immunopathol       Date:  1994-06       Impact factor: 2.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.